Valuation Rekah Pharmaceutical Industry Ltd.

Stocks

Market Closed - TEL AVIV STOCK EXCHANGE 11:24:26 2026-10-29 EDT			5-day change	1st Jan Change
1,020.00 ^ILa	0.00%		-1.35%	-6.76%

08-25	Rekah Pharmaceutical Industry Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-31	Rekah Pharmaceutical Industry Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	305.9	265.7	175.7	168.7	151.2	124.9
Change	-	-13.13%	-33.89%	-3.96%	-10.35%	-17.43%
Enterprise Value (EV) ¹	435.3	412.9	321.1	335.2	278.3	252.9
Change	-	-5.15%	-22.24%	4.38%	-16.95%	-9.14%
P/E	28.3x	40.1x	-85.5x	-24.2x	24.5x	-6.91x
PBR	1.85x	1.54x	1.08x	1.08x	0.93x	0.87x
PEG	-	-1x	1x	-0x	-0x	0x
Capitalization / Revenue	1.15x	1.01x	0.6x	0.52x	0.47x	0.41x
EV / Revenue	1.64x	1.56x	1.1x	1.04x	0.87x	0.84x
EV / EBITDA	12.4x	13.7x	9.28x	12.9x	16.1x	16.5x
EV / EBIT	20.8x	32x	24.2x	115x	-37.9x	-34.9x
EV / FCF	-40.7x	-2,008x	9.66x	33.2x	7.47x	38.4x
FCF Yield	-2.45%	-0.05%	10.4%	3.01%	13.4%	2.6%
Dividend per Share ²	-	0.8678	-	-	-	-
Rate of return	-	3.73%	-	-	-	-
EPS ²	0.9459	0.58	-0.18	-0.61	0.54	-1.583
Distribution rate	-	150%	-	-	-	-
Net sales ¹	265.5	264	292.4	321.7	321.7	301
EBITDA ¹	35.17	30.09	34.61	26.03	17.31	15.34
EBIT ¹	20.89	12.91	13.25	2.906	-7.342	-7.245
Net income ¹	10.8	6.624	-2.041	-6.91	6.206	-18.07
Net Debt ¹	129.4	147.2	145.4	166.4	127.1	128
Reference price ²	26.80	23.28	15.39	14.78	13.25	10.94
Nbr of stocks (in thousands)	11,415	11,415	11,415	11,415	11,415	11,415
Announcement Date	3/22/21	3/30/22	3/29/23	3/26/24	3/31/25	3/30/26

¹ILS in Million²ILS

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
REKAH PHARMACEUTICAL INDUSTRY LTD.	-	-	-	-	37.43M
ELI LILLY AND COMPANY	40.35x	13.85x	30.26x	0.5%	1,224B
JOHNSON & JOHNSON	40.28x	6.76x	19.02x	1.94%	662B
ABBVIE INC.	38.08x	8.51x	17.61x	2.36%	514B
ROCHE HOLDING AG	21.65x	5.25x	13.07x	2.49%	388B
MERCK & CO., INC.	106.67x	5.95x	25.48x	2.33%	361B
NOVARTIS AG	22.86x	5.89x	14.22x	2.75%	302B
ASTRAZENECA PLC	22.82x	4.6x	13.15x	1.92%	271B
AMGEN INC.	29.23x	7.45x	13.34x	2.19%	249B
GILEAD SCIENCES, INC.	-47.64x	7.37x	28.55x	1.99%	205B
Average	30.48x	7.29x	19.41x	2.05%	417.69B
Weighted average by Cap.	36.66x	8.71x	21.55x	1.73%